The pathogenesis of SSc is incompletely understood, but several lines of evidence suggest
that B cells are involved. Effector B (Beff) cells are hyperactivated and produce …

Chronic lung rejection, also called chronic lung allograft dysfunction (CLAD), remains the
major hurdle limiting long-term survival after lung transplantation, and limited therapeutic …

Chronic graft-versus-host disease (cGVHD) is a leading cause of late morbidity and mortality
after allogenic hematopoietic stem cell transplantation. Corticosteroid-based therapies are a …

Belumosudil mesylate is a selective Rho‐associated coiled‐coil kinase 2 inhibitor with
immunomodulatory and antifibrosis effects. This multicenter, open‐label, single‐arm study …

Background. Graft‐versus‐host disease (GVHD) is a potentially fatal complication of
allogeneic hematopoietic stem cell transplant. The mainstay of treatment is corticosteroids …

Chronic graft-versus-host disease (cGvHD) is a common complication after allogeneic
haematopoietic stem cell transplantation, characterised by a broad disease spectrum that …

Chronic graft-versus-host disease (cGvHD) is a multisystem disorder that occurs in
recipients of allogeneic hematopoietic (alloHCT) stem cell transplants and is characterized …

Objectives Chronic graft-versus-host disease (cGVHD) represents a significant adverse
event that may ensue following allogeneic hematopoietic stem cell transplantation (Allo …

Donor lymphocyte infusion (DLI) is a therapeutic modality for relapsed hematological
malignancies after allogeneic hematopoietic stem cell transplantation. We retrospectively …

Method: We incorporated search engines from PubMed, Embase, Cochrane Library,
Scopus, Web of Science, and ClinicalTrials. gov. The study was performed following the …